Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Tolterodine Tartrate, and when can generic versions of Tolterodine Tartrate launch?

Tolterodine Tartrate is a drug marketed by Ivax Sub Teva Pharms, Macleods Pharms Ltd, Torrent Pharms Ltd, Teva Pharms Usa, Mylan Pharms Inc, and Apotex Corp. and is included in seven NDAs.

The generic ingredient in TOLTERODINE TARTRATE is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the tolterodine tartrate profile page.

Summary for Tradename: TOLTERODINE TARTRATE

Suppliers / Packagers: see list10
Bulk Api Vendors: see list97
Clinical Trials: see list82
Patent Applications: see list2,590
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: TOLTERODINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
tolterodine tartrate
TABLET;ORAL077006-001Feb 23, 2015ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL079141-001Nov 22, 2016ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
tolterodine tartrate
TABLET;ORAL203409-002Aug 31, 2015ABRXNoNo► Subscribe► Subscribe
Apotex Corp
tolterodine tartrate
TABLET;ORAL200164-002Sep 25, 2012ABRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL079141-002Nov 22, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus